Showing 581 - 600 results of 936 for search '"cognitive impairment"', query time: 0.07s Refine Results
  1. 581

    Impairments in Brain Perfusion, Metabolites, Functional Connectivity, and Cognition in Severe Asymptomatic Carotid Stenosis Patients: An Integrated MRI Study by Tao Wang, Feng Xiao, Guangyao Wu, Jian Fang, Zhenmeng Sun, Hongliang Feng, Junjian Zhang, Haibo Xu

    Published 2017-01-01
    “…However, recent studies have demonstrated that these asymptomatic carotid artery stenosis (aCAS) patients had cognitive impairment in tests of executive function, psychomotor speed, and memory, indicating that “asymptomatic” carotid stenosis may not be truly asymptomatic. …”
    Get full text
    Article
  2. 582

    Cognition and Vascular Risk Factors: An Epidemiological Study by Augusto Vicario, Mildren Del Sueldo, Ruth A. Fernández, Julio Enders, Judith Zilberman, Gustavo H. Cerezo

    Published 2012-01-01
    “…Out of the 4 studied RF, the only one that was not related to cognitive impairment was dyslipemia. Finally, we noted the importance of cognitive state early detection in all age groups, even in the youngest group. …”
    Get full text
    Article
  3. 583

    Patterns of Change in Cognitive Function over Six Months in Adults with Chronic Heart Failure by Barbara Riegel, Christopher S. Lee, Dale Glaser, Stephen T. Moelter

    Published 2012-01-01
    “…As some of the factors related to cognitive impairment are modifiable, research is needed to identify interventions to preserve and improve cognition in these patients.…”
    Get full text
    Article
  4. 584

    Determining influences of intraoperative s-ketamine on postoperative delirium and cognitive function: methodology is important by Dan-Feng Wang, Fei Gao, Fu-Shan Xue

    Published 2024-12-01
    “…Our main concerns include lacking the times and number of delirium monitoring per postoperative day, alone use of the Confusion Assessment Method form for delirium screening, not providing the factors related to the occurrence of postoperative delirium in the ICU stay, and application of a non-standard definition for postoperative cognitive impairment. We believe that clarification of these issues is useful for improving the transparency of their methodology and facilitating the interpretation of their results.…”
    Get full text
    Article
  5. 585

    Cognitive disorders: Potential astrocyte-based mechanism by Shiyu Li, Yeru Chen, Gang Chen

    Published 2025-01-01
    “…Cognitive impairments negatively affect patients' daily lives. …”
    Get full text
    Article
  6. 586

    Brain computer interfaces for cognitive enhancement in older people - challenges and applications: a systematic review by Ping-Chen Tsai, Asangaedem Akpan, Kea-Tiong Tang, Heba Lakany

    Published 2025-01-01
    “…This systematic review addresses BCI applications and challenges in the standard practice of EEG-based neurofeedback (NF) training in healthy older people or older people with mild cognitive impairment (MCI). Methods Articles were searched via MEDLINE, PubMed, SCOPUS, SpringerLink, and Web of Science. 16 studies between 1st January 2010 to 1st November 2024 are included after screening using PRISMA. …”
    Get full text
    Article
  7. 587

    Deciphering the Role of Adrenergic Receptors in Alzheimer’s Disease: Paving the Way for Innovative Therapies by Androulla N. Miliotou, Andria Kotsoni, Lefteris C. Zacharia

    Published 2025-01-01
    “…AD is a complex multifactorial neurodegenerative disorder characterized by progressive and severe cognitive impairment and memory loss. It is the most common cause of progressive memory loss (dementia) in the elderly, and to date, there is no effective treatment to cure or slow disease progression substantially. …”
    Get full text
    Article
  8. 588

    Different Cognitive Profiles of Patients with Severe Aphasia by Chiara Valeria Marinelli, Simona Spaccavento, Angela Craca, Paola Marangolo, Paola Angelelli

    Published 2017-01-01
    “…Three different subgroups of patients with different types and severity of cognitive impairment were evidenced. Subgroups differed as to residual linguistic skills, in particular comprehension and reading-writing abilities. …”
    Get full text
    Article
  9. 589

    The Takeda Three Colors Combination Test: A Screening Test for Detection of Very Mild Alzheimer’s Disease by Shinya Takeda, Kayo Tajime, Toshiatsu Taniguchi

    Published 2014-01-01
    “…In this study, we examined the usefulness of the Takeda Three Colors Combination Test (TTCC) for screening of the very mild AD and amnestic mild cognitive impairment (aMCI). Methods. 154 senior persons participated in the research: 55 with very mild AD, 45 with aMCI, and 54 control group. …”
    Get full text
    Article
  10. 590

    Cognitive Assessment of Very Preterm School-age Children by Chronological vs. Corrected Age by Yolanda Sánchez-Sandoval, Agustina Lambrisca, Isabel Benavente-Fernández, Laura Lacalle, Melissa L. Martínez-Shaw

    Published 2025-01-01
    “…The percentage of children whose scores could be classified as cognitively impaired was not affected by the correction. …”
    Get full text
    Article
  11. 591

    Recurrent Falls in Parkinson’s Disease: A Systematic Review by Natalie E. Allen, Allison K. Schwarzel, Colleen G. Canning

    Published 2013-01-01
    “…Factors associated with recurrent falls include: a positive fall history, increased disease severity and duration, increased motor impairment, treatment with dopamine agonists, increased levodopa dosage, cognitive impairment, fear of falling, freezing of gait, impaired mobility and reduced physical activity. …”
    Get full text
    Article
  12. 592

    The Effect of Deworming Using Triple-Dose Albendazole on Nutritional Status of Children in Perobatang Village, Southwest Sumba, Indonesia by Saleha Sungkar, Asri S. Ridwan, Gladys Kusumowidagdo

    Published 2017-01-01
    “…High prevalence of STH leads to malnutrition, anemia, cognitive impairment, and growth disorders. Triple-dose albendazole 400 mg is a broad-spectrum anthelminthic; however, its effectiveness varies in every region. …”
    Get full text
    Article
  13. 593

    Schizophrenia and Nicotine - A Bittersweet Psychiatric Story by Satrajit Ghosal, Ankit Halder, Sarthak Keshri, Navna Panchami Ravindran, Akhil Joshi

    Published 2025-01-01
    “…Conclusions: Hence, to conclude, whether nicotine has indeed a beneficial effect on cognition in schizophrenia has to be investigated longitudinally so that a possible treatment option to address cognitive impairment in schizophrenia is obtained. Extensive longitudinal studies needs to be conducted to better understand the long-term effect of tobacco use and cognition in schizophrenia patients.…”
    Get full text
    Article
  14. 594

    Enhanced Neuroplasticity by the Metabolic Enhancer Piracetam Associated with Improved Mitochondrial Dynamics and Altered Permeability Transition Pore Function by Carola Stockburger, Davide Miano, Thea Pallas, Kristina Friedland, Walter E. Müller

    Published 2016-01-01
    “…The mitochondrial cascade hypothesis of dementia assumes mitochondrial dysfunction leading to reduced energy supply, impaired neuroplasticity, and finally cell death as one major pathomechanism underlying the continuum from brain aging over mild cognitive impairment to initial and advanced late onset Alzheimer’s disease. …”
    Get full text
    Article
  15. 595

    Functional MRI Assessment of Task-Induced Deactivation of the Default Mode Network in Alzheimer’s Disease and At-Risk Older Individuals by Maija Pihlajamäki, Reisa A. Sperling

    Published 2009-01-01
    “…Our recent studies have revealed alterations in the pattern of deactivation also in elderly individuals at risk for AD by virtue of their APOE e4 genotype, or evidence of mild cognitive impairment (MCI). In agreement with recent reports from other groups, these studies demonstrate that the pattern of fMRI task-induced deactivation is progressively disrupted along the continuum from normal aging to MCI and to clinical AD and more impaired in e4 carriers compared to non-carriers. …”
    Get full text
    Article
  16. 596

    Caffeic Acid Phenethyl Ester Protects Neurons Against Oxidative Stress and Neurodegeneration During Traumatic Brain Injury by Nurul Sulimai, Jason Brown, David Lominadze

    Published 2025-01-01
    “…The results suggest that Fg-induced generation of ROS could be a mechanism involved in cognitive impairment and that CAPE can offer protection against oxidative damage and neurodegeneration.…”
    Get full text
    Article
  17. 597

    Bidirectional association between breast cancer and dementia: a systematic review and meta-analysis of observational studies by Fuxing Bao, Liang Yu, Xiaolei Zhang, Qier Mu

    Published 2025-01-01
    “…Background Cognitive decline following cancer treatment can vary from mild cognitive impairment to severe dementia. However, there is inconsistent evidence regarding the relationship between breast cancer survivors and their risk of developing dementia. …”
    Get full text
    Article
  18. 598

    Intramuscular Olanzapine in the Management of Behavioral and Psychological Symptoms in Hospitalized Older Adults: A Retrospective Descriptive Study by Silvia Duong, Kam-Tong Yeung, Feng Chang

    Published 2015-01-01
    “…Among 82 patients aged 65–96 years (mean ± SD 79.3 ± 7.7) 85 cases were identified. Cognitive impairment or dementia affected 63.5% and 50.6% had comorbidities. …”
    Get full text
    Article
  19. 599

    Elderly in the state of co-residence in a town in State Bahia, Brazil by Saulo Sacramento Meira, Alba Benemérita Alves Vilela, Cezar Augusto Casotti, Jorge Costa do Nascimento, Camila Barros Andrade

    Published 2015-04-01
    “…This is a cross-sectional, descriptive and exploratory household survey, by simple random sample, with individuals over 60 years, residents and enrolled in a health unit’s family in Jequié / BA and who has shown no cognitive impairment. Data were collected through a multidimensional question- naire Brazil Old Age Schedule (BOAS), tabulated and analyzed by Epi Info 3.3.2 program. …”
    Get full text
    Article
  20. 600

    Suvorexant, a Novel Dual Orexin Receptor Antagonist, for the Management of Insomnia by Andrew H. Han, Caroline R. Burroughs, Evan P. Falgoust, Jamal Hasoon, Grace Hunt, Juyeon Kakazu, Tim Lee, Adam M. Kaye, Alan D. Kaye, Latha Ganti

    Published 2023-01-01
    “…The most common adverse effects include dizziness, somnolence, headaches, and cognitive impairment. # Summary Insomnia is a major public health concern that affects many people worldwide and has been linked to many adverse health outcomes. …”
    Get full text
    Article